Somatic Advantage 500 Standard (DNA+RNA) (Rapid)

Test Code
SLS162015
Book Now

What is Somatic Advantage 500 Standard (DNA+RNA) (Rapid)?

The Somatic Advantage 500 – Rapid (SA500 Rapid) is a fast-tracked version of our comprehensive genomic profiling assay for solid tumors. It analyzes over 500 cancer-related genes through DNA and RNA sequencing, and includes assessment of Tumor Mutation Burden (TMB) and Microsatellite Instability (MSI). Built for urgent clinical decision-making, SA500 Rapid delivers the same high-quality insights as the standard version—but with a significantly reduced turnaround time.
Genes Covered/ No. of Genes: 523 Genes, 55 Fusions, Tumour Mutation Burden (TMB), Microsatellite Instability (MSI)

Who Is This Test For?

  • Patients with aggressive or rapidly progressing cancers requiring urgent treatment decisions
  • Individuals with advanced or metastatic solid tumors being considered for targeted therapies or immunotherapies
  • Cancer cases where timely genomic profiling can determine eligibility for clinical trials
  • Patients with Cancers of Unknown Primary (CUP) needing swift molecular characterization

Key Features

  • 500+ gene coverage with AMP Tier I/II/III variant reporting
  • UMI-based library prep for enhanced detection sensitivity and accuracy
  • RNA fusion detection to capture clinically relevant gene rearrangements
  • Includes TMB and MSI analysis for immunotherapy guidance

Clinical Applications

  • Enables rapid identification of actionable targets for precision therapies
  • Supports eligibility for immune checkpoint inhibitors based on TMB/MSI
  • Facilitates timely access to clinical trials with comprehensive genomic inclusion criteria
  • Ideal for patients needing specialized treatment planning due to aggressive or advanced disease

All Solid Tumors, Comprehensive Profiling

Contact Us